XORTX Therapeutics Inc. (XRTX)

XORTX Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019
Cash & Equivalents	10.43	14.87	0.17	0.78
Cash & Cash Equivalents	10.43	14.87	0.17	0.78
Cash Growth	-29.83%	8582.07%	-78.18%	-
Receivables	0.08	0.04	0.01	0.02
Other Current Assets	0.38	1	1.87	0.01
Total Current Assets	10.9	15.91	2.06	0.82
Property, Plant & Equipment	0.09	0	0	0
Goodwill and Intangibles	0.2	0.2	0.23	0.27
Other Long-Term Assets	1.19	1.27	0	0
Total Long-Term Assets	1.48	1.47	0.23	0.27
Total Assets	12.37	17.38	2.29	1.09
Accounts Payable	1.45	0.55	1.03	1.15
Current Debt	0.07	0	0	0.05
Other Current Liabilities	0	0	0	0.1
Total Current Liabilities	1.51	0.55	1.03	1.3
Long-Term Debt	0.01	0	0	0
Other Long-Term Liabilities	3.85	3.63	0	0
Total Long-Term Liabilities	3.87	3.63	0	0
Total Liabilities	5.38	4.18	1.03	1.3
Total Debt	0.08	0	0	0.05
Retained Earnings	-15.7	-7.98	-8.04	-6.76
Comprehensive Income	-0.05	0.08	0	0
Shareholders' Equity	7	13.2	1.26	-0.21
Net Cash / Debt	10.36	14.87	0.17	0.73
Net Cash / Debt Growth	-30.35%	8582.07%	-76.67%	-
Net Cash Per Share	7.00	13.59	0.23	1.23
Working Capital	9.38	15.36	1.02	-0.48
Book Value Per Share	4.73	12.07	1.70	-0.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).